Abstracts tagged "Fibromyalgia and treatment"

Abstract Number: 253 • ACR/ARHP Annual Meeting 2018
Fibromyalgia Patients Are Frequently Thought to be Challenging to Treat-Are They?
Robert S. Katz¹ and Lauren Kwan², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: Fibromyalgia patients can be time consuming to treat and difficult to manage. Especially challenging fibromyalgia patients tend to have many symptoms, ask many questions,…
Abstract Number: 2225 • ACR/ARHP Annual Meeting 2016
Treatment Outcomes of Newly and Formerly Diagnosed Patients with Fibromyalgia after Fibromyalgia Treatment Program
Juan Jiao¹, Connie A. Luedtke^2,3, Ann Vincent⁴ and Terry H. Oh⁵, ¹Rheumatology Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, ²Department of Nursing, Mayo Clinic, Rochester, MN, Rochester, MN, ³Department of Nursing, Mayo Clinic, Rochester, MN, ⁴General Internal Medicine, Mayo Clinic, Rochester, MN, ⁵Physical Medicine & Rehabilitation, Mayo Clinic, Rochester, MN
Background/Purpose: We compared treatment outcomes between newly diagnosed versus formerly diagnosed patients seen in the brief interdisciplinary fibromyalgia treatment program (FTP). The FTP includes diagnostic…
Abstract Number: 53 • ACR/ARHP Annual Meeting 2016
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric Observational Study
Maria Chiara Gerardi¹, Alberto Batticciotto², Rossella Talotta¹, Maria Chiara Ditto¹, Fabiola Atzeni² and Piercarlo Sarzi-Puttini¹, ¹Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, ²Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy
Efficacy of Cannabis flos in patients with fibromyalgia: a monocentric observational study Background/Purpose: Fibromyalgia (FM) is a syndrome characterized by chronic widespread pain, fatigue,…
Abstract Number: 39 • ACR/ARHP Annual Meeting 2016
Effects of Pregabalin (Lyrica®) on Cerebrospinal Fluid Substance P in Human Subjects with Fibromyalgia Syndrome
Irwin Jon Russell¹, Joel E. Michalek² and Sorleen Trevino-Mendez³, ¹Affiliated with Arthritis & Osteoporosis Center of South Texas, Medical Director, Fibromyalgia Research and Consulting, San Antonio, Texas, San Antonio, TX, ²Professor, Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, San Antonio, TX, ³Medical Student, Texas Tech University School of Medicine, Lubbock, TX
Background/Purpose: Fibromyalgia Syndrome [FMS] is a common chronic pain disorder. Pregabalin (PGB) is one of three medications approved by the FDA for treatment of FMS.…
Abstract Number: 2213 • ACR/ARHP Annual Meeting 2016
The Four Stages of Fibromyalgia: Potential for More Precise Treatment Approaches
Mark Gostine¹, Fred Davis¹, Bradley Roberts², Rebecca Risko², Joseph C Cappelleri³, Andrew Clair⁴ and Alesia Sadosky⁵, ¹Michigan Pain Consultants, PC, Grand Rapids, MI, ²ProCare Systems, Inc., Grand Rapids, MI, ³Statistics, Pfizer Inc, New London, CT, ⁴Pfizer, New York, NY, ⁵Pfizer Inc,, New York, NY
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain and tenderness making it difficult to manage. Accounting for FM heterogeneity might elicit an improvement in…
Abstract Number: 1873 • ACR/ARHP Annual Meeting 2012
Clinical Characteristics and Health Care Utilization Patterns Among Patients with Fibromyalgia Newly Prescribed Amitriptyline, Duloxetine, Gabapentin or Pregabalin: A Large Cohort Study
Seoyoung C. Kim¹, Joan E. Landon² and Daniel H. Solomon³, ¹Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Boston, MA, ³Division of Rheumatology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Patients with fibromyalgia (FM) tend to use a number of different medications and have high health care costs. Treatment for FM generally consists of…